The disposition of fluid given by i.v. infusion can be studied by fitting one-volume and twovolume kinetic models to the fractioned dilution of blood haemoglobin and serum albumin concentrations over time. However, the twovolume model is sometimes associated with a high standard error in estimating the size of the secondary (peripheral) body fluid space, V 2 . To examine if a fixed elimination rate constant (k r ) determined by urinary excretion can be used to make the model more stable, we infused Ringer's acetate 25 ml kg Volume kinetics is a model for studying how the body handles fluid given by i.v. infusion. 1 2 Dilution of the plasma volume after i.v. infusion can be analysed and simulated over time in a manner similar to drug concentrations in pharmacokinetics.
Urinary excretion as an input variable in volume kinetic analysis of Ringer's solution
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Summary
The disposition of fluid given by i.v. infusion can be studied by fitting one-volume and twovolume kinetic models to the fractioned dilution of blood haemoglobin and serum albumin concentrations over time. However, the twovolume model is sometimes associated with a high standard error in estimating the size of the secondary (peripheral) body fluid space, V 2 . To examine if a fixed elimination rate constant (k r ) determined by urinary excretion can be used to make the model more stable, we infused Ringer's acetate 25 ml kg Volume kinetics is a model for studying how the body handles fluid given by i.v. infusion. 1 2 Dilution of the plasma volume after i.v. infusion can be analysed and simulated over time in a manner similar to drug concentrations in pharmacokinetics. 3 4 The results are sensitive to analytical errors, however, and the choice of mathematical approach is relevant to the stability of the variable estimates.
The key problem is to estimate the size of the secondary (peripheral) fluid space, V 2 , which can be overestimated owing to analytical errors in the assay used to quantify dilution of the primary (central) fluid space, V 1 . 1 The precision of the estimate is also relatively poor. 3 Occasionally, it is difficult for the model to distinguish between elimination of fluid and distribution of fluid to V 2 , which results in a low elimination rate constant (k r ) and an unrealistically large V 2 . When this occurs, strong within-patient parameter covariances (r 2 -90.98) indicate that k r and V 2 behave as a single parameter. In these situations, the two-volume fluid space model has been considered invalid, 3 although it might be apparent from the dilution-time curve that the disposition of fluid occurs according to the two-volume model.
The purpose of this study was to evaluate if measured urinary excretion could be used as an input variable to make the volume kinetic model more stable, particularly with respect to V 2 . The rationale for our attempt is that nearly all fluid indicated by k r to be eliminated from the expanded fluid space can be collected as urine.
2 This allows the model to operate with k r being set to a fixed value which is determined by urinary excretion. The result might be of practical value when using volume kinetic models. The models are also of theoretical interest for our understanding of body fluid volumes and kinetic constants involved in the disposition of crystalloid fluid.
Subjects and methods
After obtaining approved from the local Ethics Committee and informed consent, we studied 15 healthy men, aged 24-42 (mean 35) yr with a body weight of 65-100 (mean 77) kg.
After an overnight fast, volunteers rested comfortably on a bed, and at least 20 min of equilibration were allowed before the experiments were started between 08:00 and 09:00. A cannula was placed in the cubital vein of each arm for blood sampling and infusing fluid, respectively. Volunteers were given an i. obtained ensured a coefficient of variation of 1.0% for B-Hb and 2.7% for serum albumin. The distribution of fluid given by i.v. infusion was analysed using volume-of-fluid-spaces kinetic models, which are summarized in figure 1. The infused fluid is assumed to occupy one or two expandable body fluid spaces and elimination occurs at a basal rate (perspiration and basal diuresis) and at a rate proportional to dilution of the central fluid space, V 1 . The differential equations describing the volume changes in the expanded body fluid spaces and their matrix solutions are shown in the appendix. Dilution of plasma volume (i.e. (v 1 -V 1 )/V 1 ), was used to quantitate fluid load. Plasma volume was chosen because extracellular fluid, but not erythrocytes, are expanded by the infused fluid. For this purpose, data on serum albumin were used directly. However, when the data on B-Hb were analysed, dilution of plasma volume was taken as the product of dilution of blood volume and (1-packed cell volume), where packed cell volume was assumed to decrease in proportion to the reduction in B-Hb. A correction for the loss of erythrocytes with blood sampling was always made. [1] [2] [3] The rate of spontaneous fluid loss from the expandable fluid space(s) (k b ) was set at 0.8 ml min
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, which includes compensation for fluid loss associated with blood sampling. We have used previously a k b value of 1.0 ml min
, but those volunteers ate a light meal before the experiments. 2 The model parameters were calculated on a computer using Matlab version 4.2 (Math Works Inc., Notich, MA, USA) in which a non-linear least squares regression routine based on a modified Gauss-Newton method was repeated until no parameter changed by more than 0.001 (0.1%) in each iteration. Curve-fitting was performed on the one-volume fluid space model (VOFS1) where the output consists of the best estimates and standard errors for V and k r . Calculations were then performed according to the two-volume fluid space model (VOFS2) where the output consists of the best estimates and standard errors for V 1 , V 2 , k r and k t . However, the results of VOFS2 were reported only if the F test indicated that it was statistically justified to fit a biexponential curve instead of a monoexponential one to the data. 5 An F value is obtained using the following equation:
where MSQ : mean square error for the difference between measured dilution of plasma volume and optimal curve fit according to VOFS1 and VOFS2, respectively; df : degrees of freedom, that is the number of data points used in fitting the function, minus the number of parameters fitted. The calculated value for F is compared with the critical value for significance in a standard statistical table. All calculations were performed both when k r was estimated together with the other parameters and also when k r was set to a fixed value determined by Figure 1 In the one-volume model (top), a fluid infused at a rate k i is distributed in an expandable space with a volume (v), which the fluid space strives to maintain at an ideal (target) volume (V). Fluid leaves the space at a basal rate (k b ) and at a controlled rate proportional by a constant (k r ) to the deviation from the target volume. In the two-volume model (bottom), the primary fluid space communicates with a secondary fluid space. The rate of volume equilibration between the expandable fluid spaces (with volumes v 1 and v 2 ) is proportional to the relative difference in deviation from the target values (V 1 and V 2 ) by a constant (k t ).
Figure 2
Volume kinetic curves from one experiment. When plasma dilution is indicated by both blood haemoglobin (top row) and serum albumin (bottom row) concentrations, the one-volume model (left) and the two-volume model (right) can generate a dilution-time curve using an elimination rate constant determined by the urinary excretion value (solid line) or by a value generated by the model (irregular line with crosses). In the latter case, the curves overlap although the model might give a lower k r and a larger V 2 .
total urinary excretion during the experiment. To calculate k r , the excreted volume of urine was divided by the integral of the dilution-time curve after assuming that half of the spontaneous elimination of fluid (k b ) also appeared as urine.
Data are presented as median (25th and 75th percentiles). Differences between methods of analysis were studied by the Wilcoxon matched pair test and the Mann-Whitney U test, as appropriate. Correlations between parameters were evaluated by linear regression, where r : correlation coefficient. P : 0.05 was considered statistically significant. Five of the 15 experiments have been used in another report. 
Results
Dilution of B-Hb and serum albumin concentrations increased during the infusions and decreased promptly during the first 30 min after the infusion was completed. Thereafter, dilution was usually restored more slowly ( fig. 2 ). Total urinary excretion was 950 ml (25th and 75th percentiles 718, 1067 ml, respectively).
Use of the urinary excretion value to calculate k r markedly increased the mean square error (MSQ) obtained when the one-volume model was fitted to the data, when both B-Hb and serum albumin were used to indicate dilution of plasma volume (table 1, fig. 2 ). The target volume, V, and the standard error associated with this estimate, became larger. The model-predicted k r was markedly higher than the k r obtained from the urine data.
The two-volume model was also applied, and we report the experiments in which this model was statistically justified. Here, application of the urine excretion-generated k r also increased MSQ, but the difference was not great (table 2). Little difference was seen when the two curve fits were compared graphically ( fig. 2, right) . The parameter standard errors were significantly reduced by applying a fixed k r instead of allowing k r to be estimated by the model, the only exception being the error associated with estimate of V 2 . However, the error of V 2 became significantly reduced when the standard error relative to the size of V 2 (i.e. the standard error divided by V 2 ) was studied.
The difference between the fixed and modelgenerated values of k r correlated inversely with the differences in target volumes (V or V 2 ) obtained in the same analyses; the regression line runs through zero in the plots for both the one-volume ( fig. 3, left) and two-volume ( fig. 3 , right) models. The size of the model-generated V 2 is expected to be approximately 10 litre (130 ml kg
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) when there is full agreement between the model-generated k r and the value calculated from urinary excretion (fig. 4) .
The experiments which generated data deviating markedly from the zero intercept in figure 3 were characterized by strong within-patient covariances between k r and V 2 (r 2 -90.98). When a solution to the two-volume model was obtained and the curve fit appeared to be statistically justified, such a high covariance between k r and V 2 was found in four of the experiments based on dilution of serum albumin (table 3) . In these cases, the absolute size of V 2 and the standard error associated with this estimate were much larger than in the other experiments.
Discussion
Volume kinetics may become an important tool to optimize fluid therapy in surgery and trauma care in the future. [1] [2] [3] [4] This approach provides knowledge on how plasma volume expansion during and after i.v. infusion of fluid changes over time. For example, the values obtained for the model parameters in tables 1 and 2 can be entered into a computer and, using the mathematical solutions presented in the appendix, simulate the dilution-time profile after any infusion rate or combinations of infusion rates of Ringer's solution. Furthermore, as dilution stems only from the infused fluid, the size of the body fluid spaces expanded by crystalloid fluid and the rates of exchange of fluid between these spaces, under optimal conditions, may be close to the real volumes and rates.
This study was designed to evaluate if volume kinetic models can be made more stable by using the urinary excretion value as an input variable in the calculations. This might be achieved by calculating the elimination rate constant (k r ) from the excreted volume of urine and the area under the curve of the dilution of B-Hb or serum albumin concentrations during and after i.v. infusion of Ringer's solution.
However, the results showed that the models usually did not become more stable when this was done. In the one-volume model, the use of a fixed k r increased the mean square error associated with the curve-fitting Figure 3 Difference between the elimination rate constant k r , as determined by urinary excretion and generated by the kinetic model, vs the difference in target volume V in the one-volume model (left) and the secondary fluid space V 2 in the two-volume model (right).
Figure 4
Difference between elimination rate constant k r , as determined by urinary excretion and generated by the kinetic model, vs the size of V 2 in the two-volume model. Each circle represents one experiment in which plasma dilution is indicated by the serum albumin concentration. One extreme outlier has been omitted. The plot indicates that V 2 is approximately 10 litre when both methods for determining k r agree fully. Table 3 Volume kinetic variables in the two-volume fluid space model based on analysis of serum albumin data, depending on whether there is a strong within-patient covariance between k r and V 2 . The data shown are the size of V 2 and the standard error associated with this estimate, and ∆k r which is the difference between the k r from the urinary excretion and that obtained from the model. and the standard error involved in estimating the size of the single expanded body fluid space. This implies no benefit. The curve fit shown in figure 2 also illustrates clearly that the k r fixed by urinary excretion was a poor estimator of the shape properties of the dilution curve. When the two-volume model was applied to the data, however, the shape of the dilution curve appeared very similar when the fixed and model-predicted values of k r were used. The parameter standard errors became reduced when using a fixed k r , but the improvements were approximately those expected when determining three parameters instead of four. Although significant, the improved precision was not large enough to warrant a new practice for performing these calculations. There is one special situation, however, when the use of a fixed k r seems to be warranted. When the F test indicates that the two-volume model is statistically justified but the conventional method of obtaining model-generated estimates of all four parameters shows a strong within-patient covariance between V 2 and k r (r between 90.98 and 91.00), the size of V 2 is given with so poor a precision that the estimate does not contain any real information. In these cases, the model-generated value of k r differs considerably from that indicated by urinary excretion. When this situation occurs, it would be justified to use urinary excretion to calculate k r , because this is a better choice than to accept the optimal curve fit generated by the one-volume model. In our study, we found such strong covariances only when dilution of V 1 was indicated by serum albumin concentration, but in subsequent experiments we have confirmed that the "galloping" V 2 can be found also when B-Hb concentration is used.
Comparison between the values of V 2 and k r obtained when using a fixed k r offered some further theoretical basis for the "true" size of V 2 . When the model-generated k r differs from the fixed value, the size of V 2 is also likely to differ by a magnitude that is predictable. A plot of these differences indicates that the zero difference between the two analytical approaches corresponds to a size of V 2 of approximately 10 litre. This size should represent the most accurate estimate of the volume of the peripheral fluid space that is expanded by the infused fluid. However, our view is valid only if k r represents urinary excretion and that the difference between the two values of k r is correct.
The volume of 10 litre for V 2 was a few litres less than the expected size of the interstitial fluid volume, but is not unreasonable as the interstitial fluid space of the central nervous system and bone tissue can hardly be expanded by Ringer's solution. It should be emphasized that the size of an expandable fluid space can only be determined by expanding it. This volume is not available for measurement by tracer techniques. Although not elaborated upon in this study, the reader should observe that some experiments are better explained by a one-volume kinetic model than by a two-volume one, and that the total size of the expandable body fluid space in those cases is usually smaller compared with when the two-volume model is justified. 2 3 The other parameters in the two-volume model were less affected than V 2 and k r when the urinary excretion value was used as an input variable. The size of the primary (central) fluid space, V 1 , was 3.4-4.3 litre, which suggests that it corresponds to plasma volume. These parameters were estimated with a standard error of approximately 10%, although the error was somewhat larger when k r was generated by the model. The constant k t , which governs diffusion of fluid between the primary and secondary fluid spaces, did not differ significantly depending on whether or not a fixed k r was applied.
The problem with a strong covariance between V 2 and k r stems in part from the choice of method used to perform the volume kinetic analysis. The first approach used was the random search method which tests different parameter values to minimize the squared difference (MSQ) between a modelgenerated curve and the experimental data. 1 2 The iterations continue until no further improvement of the fit is obtained in 15 trials. The second approach, which is based on matrix algebra to facilitate future modifications of the model, also repeats an algorithm until the MSQ is minimized. However, the model works by adding corrections to the previous parameter values, and the corrections are based on the derivative of a gradient function. No testing of random values is involved. The model continues to search for the optimal parameter values until none is changed by more than 0.1% in each iteration. The confidence interval for the minimum represents an ellipsoid area in the parameter space, and the precision of the parameter value can be poor if this area is very long and narrow. 3 4 The "galloping" V 2 implies that the iterations continue with a progressive increase in V 2 and a decrease in k r when MSQ is already very low. This problem did not occur with the random search method, but we have realized that the precision of V 2 given by this algorithm is always poor in the experiments where the Gauss-Newton method results in a "galloping" V 2 . Thus there is a need for making the two-volume model more stable in certain experiments when the random search method is also used. Good precision of the parameter estimates is essential if we wish to improve our understanding of the real body fluid volumes and kinetic constants involved in the disposition of crystalloid fluid.
In summary, the urinary excretion value can be used to make the two-volume kinetic model more stable in cases where the correlation matrix indicates strong within-patient covariance between V 2 and k r . This approach is not clearly justified in other situations.
The mathematical models describing the one-volume and two-volume models are linear differential equations with constant coefficients and their solutions can be given analytically in different forms. The single fluid space model is easily solved as a monoexponential solution. 1 4 The solution of the two-volume fluid space model used in this study is based on the matrix exponential e At 
